in vitro testing of antimicrobial activity of bone cement
synergism between amodiaquine and its major metabolite, desethylamodiaquine, against plasmodium falciparum in vitro
modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of ..
antipneumococcal activities of two novel macrolides, gw 773546 and gw 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and te..
activities of two novel macrolides, gw 773546 and gw 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against haemophilu..
chemical diversity of polyene macrolides produced by streptomyces noursei atcc 11455 and recombinant strain erd44 with genetically altered polyketide synthase nysc
emergence of multidrug-resistant salmonella enterica serovar typhi in korea
four variants of the citrobacter freundii ampc-type cephalosporinases, including novel enzymes cmy-14 and cmy-15, in a proteus mirabilis clone widespread in poland
effects of amoxicillin subinhibitory concentrations on the cross-protection developed by pneumococcal antibodies in mouse sepsis caused by an amoxicillin-resistant ..
nevirapine significantly reduces the levels of racemic methadone and ( r )-methadone in human immunodeficiency virus-infected patients
novel chemical class of pul97 protein kinase-specific inhibitors with strong anticytomegaloviral activity
multidrug resistance of a porin deletion mutant of mycobacterium smegmatis
inhibition of antibiotic efflux in bacteria by the novel multidrug resistance inhibitors biricodar (vx-710) and timcodar (vx-853)
promoter sequences necessary for high-level expression of the plasmid-associated ampc ß-lactamase gene bla mir-
emergence and persistence of macrolide resistance in oropharyngeal flora and elimination of nasal carriage of staphylococcus aureus after therapy with slow-release ..
differential maintenance of the m184v substitution in the reverse transcriptase of human immunodeficiency virus type 1 by various nucleoside antiretroviral agents i..
pharmacodynamics of pulse dosing versus standard dosing: in vitro metronidazole activity against bacteroides fragilis and bacteroides thetaiotaomicron
pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligr..
highly active anti- pneumocystis carinii compounds in a library of novel piperazine-linked bisbenzamidines and related compounds
oxa-60, a chromosomal, inducible, and imipenem-hydrolyzing class d ß-lactamase from ralstonia pickettii
hypermutation and the preexistence of antibiotic-resistant pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections
comparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria
evolution of the antimicrobial resistance of staphylococcus spp. in spain: five nationwide prevalence studies, 1986 to 200
concentrations of gemifloxacin at the target site in healthy volunteers after a single oral dose
complex multiple antibiotic and mercury resistance region derived from the r-det of nr1 (r100)
steady-state pharmacokinetics of a double-boosting regimen of saquinavir soft gel plus lopinavir plus minidose ritonavir in human immunodeficiency virus-infected ad..
infections with nontyphoidal salmonella species producing tem-63 or a novel tem enzyme, tem-131, in south africa
in vivo assessment of drug efficacy against plasmodium falciparum malaria: duration of follow-up
heterologous expression of the enterococcal vana operon in methicillin-resistant staphylococcus aureus
activity of the new triazole derivative albaconazole against trypanosoma ( schizotrypanum ) cruzi in dog hosts
rapid direct detection of multiple rifampin and isoniazid resistance mutations in mycobacterium tuberculosis in respiratory samples by real-time pcr
mutations of pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis
potential for interactions between caspofungin and nelfinavir or rifampin
novel approach to characterization of combined pharmacodynamic effects of antimicrobial agents
lb11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant s..
effects of valproic acid coadministration on plasma efavirenz and lopinavir concentrations in human immunodeficiency virus-infected adults
maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant wo..
inhibition of adherence and killing of candida albicans with a 23-mer peptide (fn/23) with dual antifungal properties
delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models of human papillomavirus-assoc..
n-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block vi..
usnic acid, a natural antimicrobial agent able to inhibit bacterial biofilm formation on polymer surfaces
analysis of mupirocin resistance and fitness in staphylococcus aureus by molecular genetic and structural modeling techniques
molecular mechanisms of primary resistance to flucytosine in candida albicans
in vitro combination of amdoxovir and the inosine monophosphate dehydrogenase inhibitors mycophenolic acid and ribavirin demonstrates potent activity against wild-t..
platelet microbicidal protein 1: structural themes of a multifunctional antimicrobial peptide
in vitro evolution of itraconazole resistance in aspergillus fumigatus involves multiple mechanisms of resistance
anti- aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals
dose-dependent resorption of quinine after intrarectal administration to children with moderate plasmodium falciparum malaria
evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enteroc..
activity of opt-80, a novel macrocycle, compared with those of eight other agents against selected anaerobic species
community-onset disease caused by citrobacter freundii producing a novel ctx-m ß-lactamase, ctx-m-30, in canada
plasmid-mediated carbapenem-hydrolyzing enzyme kpc-2 in an enterobacter sp.
altered susceptibility of candida glabrata bloodstream isolates to triazoles at clinically relevant ph values: comparison of the nccls m27-a2, sensititre yeastone, ..
antibiotic susceptibility in neonatal invasive isolates of streptococcus agalactiae in a 2-year nationwide surveillance study in germany
novel mutations within the embb gene in ethambutol-susceptible clinical isolates of mycobacterium tuberculosis
antimicrobial and antileishmanial activities of hypocrellins a and b
in vitro pharmacodynamic characteristics of amphotericin b, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent candida species fr..
quinolone-resistant haemophilus influenzae : determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin
antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 200
shv-49, a novel inhibitor-resistant ß-lactamase in a clinical isolate of klebsiella pneumoniae
in vitro susceptibilities of mycoplasma hyopneumoniae field isolates
decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease
pharmacokinetics of indinavir at 800, 600, and 400 milligrams administered with ritonavir at 100 milligrams and efavirenz in ethnic chinese patients infected with h..
activity of tigecycline (gar-936) against acinetobacter baumannii strains, including those resistant to imipenem
pharmacodynamics of ceftazidime plus the serine ß-lactamase inhibitor am-112 against escherichia coli containing tem-1 and ctx-m-1 ß-lactamases
nonisotopic, semiautomated plasmodium falciparum bioassay for measurement of antimalarial drug levels in serum or plasma
comparison of simultaneous splenic sample pcr with blood sample pcr for diagnosis and treatment of experimental ehrlichia canis infection